Standardized mean differences (SMDs, d) reported for continuous baseline characteristics show well-balanced matched populations; effect size d (absolute values of d: small effect d < 0.2, medium effect d between 0.2 and 0.8, large effect d > 0.8). Values are expressed as a median with interquartile range (IQR); n = 32 per group
. | RFC–ACS . | IFC–ACS . | d . |
---|---|---|---|
PCI characteristics | |||
Total stented length (mm) | 26.0 ± 30.6 | 23.0 ± 11.5 | 0.08 |
Largest stent diameter (mm) | 3.5 ± 0.50 | 3.4 ± 1.0 | 0.05 |
Patient characteristics | |||
Age (years) | 62.0 ± 16.75 | 61.0 ± 16.5 | 0.04 |
BMI (kg/m2) | 25.5 ± 6.1 | 25.6 ± 3.9 | 0.08 |
Laboratory data | |||
Total cholesterol (mg/l) | 204.0 ± 61.0 | 179.0 ± 50.2 | 0.49 |
LDL cholesterol (mg/l) | 129.0 ± 53.0 | 113.0 ± 44.5 | 0.56 |
HDL cholesterol (mg/l) | 40.0 ± 14.0 | 50.0 ± 20.0 | 0.23 |
Serum creatinine (mg/l) | 0.94 ± 0.2 | 0.97 ± 0.2 | 0.17 |
Hemoglobin (g/dl) | 14.7 ± 1.8 | 14.8 ± 1.6 | 0.09 |
Leukocytes (per nl) | 10.5 ± 4.3 | 11.0 ± 6.0 | 0.16 |
hsCRP (mg/l) | 2.1 ± 5.4 | 2.0 ± 3.2 | 0.19 |
ACS characteristics | |||
CK peak (U/I) | 902.0 ± 720 | 569.0 ± 1.063 | 0.13 |
. | RFC–ACS . | IFC–ACS . | d . |
---|---|---|---|
PCI characteristics | |||
Total stented length (mm) | 26.0 ± 30.6 | 23.0 ± 11.5 | 0.08 |
Largest stent diameter (mm) | 3.5 ± 0.50 | 3.4 ± 1.0 | 0.05 |
Patient characteristics | |||
Age (years) | 62.0 ± 16.75 | 61.0 ± 16.5 | 0.04 |
BMI (kg/m2) | 25.5 ± 6.1 | 25.6 ± 3.9 | 0.08 |
Laboratory data | |||
Total cholesterol (mg/l) | 204.0 ± 61.0 | 179.0 ± 50.2 | 0.49 |
LDL cholesterol (mg/l) | 129.0 ± 53.0 | 113.0 ± 44.5 | 0.56 |
HDL cholesterol (mg/l) | 40.0 ± 14.0 | 50.0 ± 20.0 | 0.23 |
Serum creatinine (mg/l) | 0.94 ± 0.2 | 0.97 ± 0.2 | 0.17 |
Hemoglobin (g/dl) | 14.7 ± 1.8 | 14.8 ± 1.6 | 0.09 |
Leukocytes (per nl) | 10.5 ± 4.3 | 11.0 ± 6.0 | 0.16 |
hsCRP (mg/l) | 2.1 ± 5.4 | 2.0 ± 3.2 | 0.19 |
ACS characteristics | |||
CK peak (U/I) | 902.0 ± 720 | 569.0 ± 1.063 | 0.13 |
Standardized mean differences (SMDs, d) reported for continuous baseline characteristics show well-balanced matched populations; effect size d (absolute values of d: small effect d < 0.2, medium effect d between 0.2 and 0.8, large effect d > 0.8). Values are expressed as a median with interquartile range (IQR); n = 32 per group
. | RFC–ACS . | IFC–ACS . | d . |
---|---|---|---|
PCI characteristics | |||
Total stented length (mm) | 26.0 ± 30.6 | 23.0 ± 11.5 | 0.08 |
Largest stent diameter (mm) | 3.5 ± 0.50 | 3.4 ± 1.0 | 0.05 |
Patient characteristics | |||
Age (years) | 62.0 ± 16.75 | 61.0 ± 16.5 | 0.04 |
BMI (kg/m2) | 25.5 ± 6.1 | 25.6 ± 3.9 | 0.08 |
Laboratory data | |||
Total cholesterol (mg/l) | 204.0 ± 61.0 | 179.0 ± 50.2 | 0.49 |
LDL cholesterol (mg/l) | 129.0 ± 53.0 | 113.0 ± 44.5 | 0.56 |
HDL cholesterol (mg/l) | 40.0 ± 14.0 | 50.0 ± 20.0 | 0.23 |
Serum creatinine (mg/l) | 0.94 ± 0.2 | 0.97 ± 0.2 | 0.17 |
Hemoglobin (g/dl) | 14.7 ± 1.8 | 14.8 ± 1.6 | 0.09 |
Leukocytes (per nl) | 10.5 ± 4.3 | 11.0 ± 6.0 | 0.16 |
hsCRP (mg/l) | 2.1 ± 5.4 | 2.0 ± 3.2 | 0.19 |
ACS characteristics | |||
CK peak (U/I) | 902.0 ± 720 | 569.0 ± 1.063 | 0.13 |
. | RFC–ACS . | IFC–ACS . | d . |
---|---|---|---|
PCI characteristics | |||
Total stented length (mm) | 26.0 ± 30.6 | 23.0 ± 11.5 | 0.08 |
Largest stent diameter (mm) | 3.5 ± 0.50 | 3.4 ± 1.0 | 0.05 |
Patient characteristics | |||
Age (years) | 62.0 ± 16.75 | 61.0 ± 16.5 | 0.04 |
BMI (kg/m2) | 25.5 ± 6.1 | 25.6 ± 3.9 | 0.08 |
Laboratory data | |||
Total cholesterol (mg/l) | 204.0 ± 61.0 | 179.0 ± 50.2 | 0.49 |
LDL cholesterol (mg/l) | 129.0 ± 53.0 | 113.0 ± 44.5 | 0.56 |
HDL cholesterol (mg/l) | 40.0 ± 14.0 | 50.0 ± 20.0 | 0.23 |
Serum creatinine (mg/l) | 0.94 ± 0.2 | 0.97 ± 0.2 | 0.17 |
Hemoglobin (g/dl) | 14.7 ± 1.8 | 14.8 ± 1.6 | 0.09 |
Leukocytes (per nl) | 10.5 ± 4.3 | 11.0 ± 6.0 | 0.16 |
hsCRP (mg/l) | 2.1 ± 5.4 | 2.0 ± 3.2 | 0.19 |
ACS characteristics | |||
CK peak (U/I) | 902.0 ± 720 | 569.0 ± 1.063 | 0.13 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.